Clinical Study on the Efficacy and Safety of BAT5906 Injection
NCT05141994
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Wet Age-related Macular Degeneration
Interventions
DRUG:
2.5mg of BAT5906
DRUG:
4mg of BAT5906
Sponsor
Bio-Thera Solutions